Marlio Charles Mosseri insider trades: Nuvectis Pharma (NVCT) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Marlio reports to the SEC
Open-market buys and sales
25 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | NVCT | ↑ Buy | 50,000 | $18.32 | $916K | By Emerald Hill Ventures SARL SPF. | Jul 1, 2026 (1d) |
| Oct 27, 2025 | NVCT | ↑ Buy | 154,770 | $6.18 | $957K | By Emerald Hill Ventures SARL SPF. | Oct 29, 2025 (2d) |
| Jun 20, 2025 | NVCT | ↑ Buy | 5,603 | $7.99 | $45K | By Emerald Hill Ventures SARL SPF. | Jun 24, 2025 (4d) |
| Jun 18, 2025 | NVCT | ↑ Buy | 33,442 | $8.06 | $270K | By Emerald Hill Ventures SARL SPF. | Jun 20, 2025 (2d) |
| May 12, 2025 | NVCT | ↑ Buy | 21,167 | $8.11 | $172K | By Emerald Hill Ventures SARL SPF. | May 13, 2025 (1d) |
| May 8, 2025 | NVCT | ↑ Buy | 27,411 | $8.60 | $236K | By Emerald Hill Ventures SARL SPF. | May 9, 2025 (1d) |
| Feb 7, 2025 | NVCT | ↑ Buy | 240,000 | $5.00 | $1.2M | By Emerald Hill Ventures SARL SPF. | Feb 11, 2025 (4d) |
| Dec 13, 2024 | NVCT | ↑ Buy | 17,000 | $4.70 | $80K | Direct | Dec 16, 2024 (3d) |
| Jul 31, 2023 | NVCT | ↑ Buy | 860 | $13.88 | $12K | Direct | Aug 1, 2023 (1d) |
| Jul 28, 2023 | NVCT | ↑ Buy | 2,584 | $13.91 | $36K | Direct | Jul 31, 2023 (3d) |
| Jul 27, 2023 | NVCT | ↑ Buy | 1,556 | $13.98 | $22K | Direct | Jul 28, 2023 (1d) |
| Jul 26, 2023 | NVCT | ↑ Buy | 10,000 | $13.97 | $140K | Direct | Jul 27, 2023 (1d) |
| Jul 21, 2023 | NVCT | ↑ Buy | 8,238 | $14.47 | $119K | Direct | Jul 24, 2023 (3d) |
| Jul 19, 2023 | NVCT | ↑ Buy | 8,000 | $14.84 | $119K | Direct | Jul 20, 2023 (1d) |
| Jul 18, 2023 | NVCT | ↑ Buy | 9,149 | $14.84 | $136K | Direct | Jul 19, 2023 (1d) |
| Jul 12, 2023 | NVCT | ↑ Buy | 3,285 | $15.09 | $50K | Direct | Jul 13, 2023 (1d) |
| Jul 11, 2023 | NVCT | ↑ Buy | 10,000 | $15.36 | $154K | Direct | Jul 12, 2023 (1d) |
| Jul 7, 2023 | NVCT | ↑ Buy | 8,948 | $15.19 | $136K | Direct | Jul 10, 2023 (3d) |
| Jul 6, 2023 | NVCT | ↑ Buy | 3,179 | $15.01 | $48K | Direct | Jul 7, 2023 (1d) |
| Jul 5, 2023 | NVCT | ↑ Buy | 1,176 | $15.52 | $18K | Direct | Jul 6, 2023 (1d) |
| Jun 26, 2023 | NVCT | ↑ Buy | 16,760 | $16.46 | $276K | Direct | Jun 27, 2023 (1d) |
| Jun 23, 2023 | NVCT | ↑ Buy | 73,175 | $17.43 | $1.3M | Direct | Jun 26, 2023 (3d) |
| Jun 22, 2023 | NVCT | ↑ Buy | 13,090 | $17.72 | $232K | Direct | Jun 23, 2023 (1d) |
| Jun 16, 2023 | NVCT | ↑ Buy | 12,700 | $17.75 | $225K | Direct | Jun 20, 2023 (4d) |
| Jun 15, 2023 | NVCT | ↑ Buy | 32,124 | $17.71 | $569K | Direct | Jun 16, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NVCT insiders
Open-market trades in the last 12 months
About Marlio Charles Mosseri's insider trades
Marlio Charles Mosseri is a 10% owner of Nuvectis Pharma (NVCT). Since Jun 15, 2023, Marlio has reported 25 open-market purchases worth $7.4M and no sales on SEC Form 4. In the last 12 months: 1 buy ($916K).
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NVCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.